Information Library
Results for: Clinical Services - North and Central America - United States
In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions. Search our library today.
- Sort by:
- Recently Added
- Title
-
World Vaccine Congress
Event — Conference Date(s): April 10 - April 13, 2012
Location: Gaylord National Resort and Conference Center, Washington, DC
-
FDA News Annual Risk Management and Drug Safety Summit
Event — Conference Date(s): November 1 - November 2, 2012
Location: Washington, DC
-
SCDM 2012
Event — Conference Date(s): September 22 - September 25, 2012
Location: Los Angeles
-
DIA US 2012
Event — Conference Date(s): June 24 - June 28, 2012
Location: Philadelphia, PA Pennsylvania Convention Center
Booth Number: 1401
-
The Contribution of Early-phase Clinical Data to a Drug’s Integrated Cardiac Safety Portfolio
Hear from the Experts — December 6, 2011
This article examines the financial and time benefits to incorporating intensive ECG and QT/QTc monitoring in early-phase clinical studies. -
Energizing Enrollment
Case Study — October 4, 2011
The rapid recruitment for this Phase III, open, randomized, controlled, multi-center study in adjuvant triple-negative breast cancer (TNBC) was completed two months earlier than planned. -
Model-Based Drug Development
Brochure — October 4, 2011
Our industry-leading model-based drug development services boost the probability of success in the New Health by enabling you to make critical decisions earlier, optimizing your resources and returns. -
Digital Pathology Central Laboratory Services Fact Sheet
Brochure — June 23, 2011
This fact sheet highlights Quintiles' digital pathology services, covering everything from scanning of slides to review and analysis - giving you a faster, easier way to scan and share this critical research data. -
Genomics Fact Sheet
Brochure — June 17, 2011
Approximately 20% of today’s U.S. Clinical Trials use genomic technology. Find out about Quintiles’ offerings in this area. -
Quintiles and Population Genetics Technologies Partner
Press Release — May 16, 2011 – Quintiles, and Population Genetics Technologies Ltd. (PGT), announced a commercial collaboration to bring genomic testing into mainstream drug development in order to produce safer, more effective medicines.

